血管阻力

  • 网络vascular resistance;pvr;svr;CVR
血管阻力血管阻力
  1. 结果:PAMD可增加脑血流量,降低脑血管阻力,对心脏功能无明显影响;

    Results : PAMD can increase CBF and decrease CVR , but have no effect of cardiac function ;

  2. A2、A3两组与其余各亚组比较,其平均动脉压、周围血管阻力和门脉血流虽有显著改善,但与B组比较仍有极显著性差异(P<0.01)。

    The MAP , SVR and PVF in group A2 and group A3 showed better improvement than those in other subgroups , but as compared with group B there were significant differences ( P < 0.01 ) .

  3. B组在155min内仍保持较低的血管阻力;

    In group B ( bovine blood ), resistance remained low at 155 min.

  4. 心率×收缩压乘积、周围血管阻力两组均无明显差异(P均>0.05)。

    Meanwhile rate-pressure product ( RPP ) and peripheral vascular resistance ( PVR ) had not significant changes between two groups ( P > 0.05 ) .

  5. 脉动指数(PI)、阻力指数(RI)、SD参数增高反映了新生儿脑血管阻力较高。

    An increased PI , RI and SD reflected a high cerebral resistence in newborns .

  6. 血管阻力指数(RI)较正常人高。

    The resistance index of vessels is higher than normal .

  7. 受体肺血管阻力为3.0~5.9wood单位,平均(4.3±1.4)wood单位;

    Recipients ′ pulmonary vascular resistance ranged from 3.0 to 5.9 wood units [ mean ( 4.3 ± 1.4 ) wood units ] ;

  8. 脑血管阻力(R)通过计算获得,心音传感器放置在心前区,ECG记录标准Ⅱ导联。

    A heart sound transducer was placed on the precordium . A standard II lead of ECG was used to record .

  9. 不同年龄组ESWL前后肾内小血管阻力指数变化及意义

    Age-related changes in intrarenal vascular resistance index before and after ESWL

  10. 结果显示:EH病人大血管阻力指数增加、顺应性下降。

    The result showed that resistance index of large vassels increased while compliance reduced in EH patients .

  11. 目的:探讨体外碎石(ESWL)前后不同年龄组肾内小血管阻力指数变化及意义。

    Objective : Changes in the intrarenal vascular resistance before and after ESWL were studied .

  12. 肾血管阻力指数RI≥0.7者肾盂积水程度均≥15mm。

    All vascular resist index ≥ 0.7 with extent of hydronephrosis ≥ 15mm .

  13. ESWL前后肾内血管阻力和尿中GAL与NAG活性变化的意义

    Changes in Intrarenal Vascular Resistance and the Levels of NAG and GAL before and after ESWL

  14. 目的观察失血性休克患者血浆肾上腺髓质素(ARM)与血管阻力变化,探讨ARM在失血性休克病理生理过程中的作用。

    Objective To investigate the relationship between plasma adrenomedullin ( ARM ) level and systemic vascular resistance index ( SVRI ), and their role in the pathogenesis of hemorrhagic shock .

  15. 目的:研究刺五加叶皂苷(ASS)对麻醉犬器官血流及血管阻力的影响。方法:ASS按7.5、15.0、30.0mg。

    Objective To study the effect of Acanthopanax senticosus saponins ( ASS ) on organ blood flow and vascular resistance in anesthetized dogs .

  16. 外周血管阻力(SVR)变化与CI相反,A和B组麻醉诱导及气管插管后SVR较基础值增加或变化不明显,而C组下降(P<0.05))。

    The systemic vascular resistance ( SVR ) slightly increased or was unchanged in group A and B but was significantly decreased in group C after induction and intubation .

  17. 本研究观察3种抗高血压方案下,达到同等血压控制后,循环前胶原更新标志物&Ⅲ型胶原氨基端肽(PⅢNP)的改变和血管阻力的改变。

    We observed the changes of circulating procollagen marker for type ⅲ collagen turnover rate , the N-terminal propeptide P ⅲ NP and vascular resistance in hypertensive patients treated with various antihypertensive regimens .

  18. 目的PTT是一项反映周围血管阻力和胸腔内压变化的无创指标,因此和微觉醒相关的血压改变可通过PTT检测。

    Objective Pulse transit time ( PTT ) is a non-invasive index which reflects changes in peripheral vascular resistance and intra-thoracic pressure .

  19. 血小板活化因子(PAF)在肝脏中主要表现为增加肝脏血管阻力及糖原分解两大作用,同时还可介导超氧化物的释放、花生四烯酸的代谢、细胞因子的生成等。

    Increasing hepatic vascular resistance and glycogenolysis are two principal effects induced by platelet-activating factor ( PAF ) in the liver .

  20. 与NS组比较,HS组和HSD治疗后肺血管阻力呈下降趋势。

    There was a tendency for the pulmonary vascular resistance to decrease in HS and HSD groups as compared with NS group .

  21. 结论尼莫地平治疗HCH具有增加脑血流量、降低脑血管阻力、提高近期疗效的作用。

    Conclusions Nimodipine can increases cerebral blood flow , decreases cerebral vascular resistence and improves short-term therapeutic outcome .

  22. 4周时HC组大鼠肾血管阻力指数显著性增加,8周时H组及HC组大鼠肾血管阻力指数均显著性增加。

    The resistance index of the rats in group HC at the end of 4 weeks and in group H and group HC at the end of 8 weeks increased significantly .

  23. 对肾血流量和肾小球滤过率均无明显改变,但均使肾血流量/心输出量增高和肾血管阻力降低(P0.01,P0.05)。

    But the ratio of renal blood flow to cardiac output all rose ( P 0 . 01 ) , whereas the renal vascular resistance all decreased ( P 0 . 05 ) .

  24. 在注入NOS抑制剂后总肺循环阻力、肺动脉阻力、体循环血管阻力均明显上升(P<0.05)。

    Total pulmonary resistance ( TPR ), pulmonary vascular resistance ( PVR ) and systemic vascular resistance ( SVR ) were increased after injected NOS inhibitor ( P < 0.05 ) .

  25. 结果:脑梗塞、TIA患者早期脑血流量下降,脑血管阻力增加。

    Results : The volume of cerebral blood flow was reduced and cerebral vascular resistance increased in the early stage of cerebral infarction and ischemic attacks .

  26. 妊娠期间子宫-胎盘血管阻力与血流的调节是非常复杂的,AngⅡ通过刺激舒血管物质前列腺素E和I的合成,维持血管压力稳定,保证妊娠时子宫-胎盘的血液供应。

    Uterus-placenta vascular resistance and adjustment of blood flow is very sophisticated during pregnancy . Ang - ⅱ can keep blood pressure stabilization and sustain uterus-placenta blood supply by stimulating vasodilator synthesis that prostaglandin-E ,ⅰ .

  27. 结论拜新同在有效降低血压的同时,可降低肾脏血管阻力,使肾血流量和GFR明显增高。

    Conclusion Slow release nifedipine substantially increases renal blood flow and GFR by decreasing renal vascular resistance and effectively decreasing systemic BP .

  28. 光镜观察肾组织学改变。结果HC组和H组血清总胆固醇及肾血管阻力指数显著性增加,而内生肌酐清除率、肾皮质一氧化氮含量显著性降低。

    Results Total serum cholesterol and resistance indices of renal blood vessels increased significantly , while creatinine clearance rate and production of nitric oxide in the renal cortex decreased markedly in group HC and group H .

  29. 应用核素肾SPECT功能检查,结果表明:肾有效血浆流量、肾小球滤过率显著增加(P<0.01),肾血管阻力显著降低(P<0.01),而肾滤过分数不受影响。

    SPECT were used for detecting renal function . The results of these evaluation indicated that there was significantly increasing in ERPF and GFR ( P0.01 ) and significant decreasing in resistance of renal vessel ( P0.01 ), and FF remained unchanged .

  30. 血流动力学参数中,血管阻力指数(RI)增高,而舒张末期血流速度(Vd)降低;

    In the blood flow parameters , the blood vessel resistence index ( RI ) increased and the blood flow speed at the end of vasodilation ( Vd ) reduced .